Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

George Lau, Ghassan Abou-Alfa, Ann-Lii Cheng, Wattana Sukeepaisarnjaroen, Tu van Dao, Yoon Koo Kang, Satheesh Chiradoni Thungappa, Masatoshi Kudo, Bruno Sangro, Robin Kate Kelley, Junji Furuse, Joong-Won Park, Patrapim Sunpaweravong, Angelica Fasolo, Thomas Yau, Tomokazu Kawaoka, Sergio Azevedo, Maria Reig, Eric Assenat, Mark Yarchoan, Aiwu Ruth He, Mallory Makowsky, Charu Gupta, Alejandra Negro, Stephen Chan

DOI: 10.1016/j.jhep.2024.07.017

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.